{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T16:52:40Z","timestamp":1793465560128,"version":"4.5.0"},"reference-count":49,"publisher":"Walter de Gruyter GmbH","issue":"10","funder":[{"name":"Research Foundation of Beijing Friendship Hospital, Capital Medical University","award":["yyqdkt2019-19"],"award-info":[{"award-number":["yyqdkt2019-19"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,10,26]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec id=\"j_jpem-2020-0742_abs_001\">\n                  <jats:title>Objectives<\/jats:title>\n                  <jats:p>Mucopolysaccharidosis III, an autosomal recessive lysosomal storage disorder, is characterized by progressive mental retardation and behavioral problems. Meta-analysis of global mucopolysaccharidosis III epidemiology, which serves as a fundamental reference for public health decision-making, was not available prior to this study. To provide a systematic review and meta-analysis of birth prevalence of mucopolysaccharidosis III in multiple countries.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec id=\"j_jpem-2020-0742_abs_003\">\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>MEDLINE and EMBASE databases were searched for original research articles on the epidemiology of mucopolysaccharidosis III from inception until 1st July, 2020. A checklist adapted from STROBE (STrengthening the Reporting of OBservational studies in Epidemiology) was used to assess the quality of all studies involved. Meta-analysis, adopting a random effects logistic model, was performed to estimate pooled birth prevalence of mucopolysaccharidosis III and its subtypes.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec id=\"j_jpem-2020-0742_abs_004\">\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Twenty-five studies screened out of 1,826 records were included for data extraction. The pooled global mucopolysaccharidosis III birth prevalence was 0.76 cases (95% CI:\u00a00.57\u20130.96) per 100,000 live births. The pooled global birth\u00a0prevalence of mucopolysaccharidosis III subtypes (A,\u00a0B,\u00a0and C) was 0.52 cases (95% CI: 0.33\u20130.72), 0.21 cases (95% CI: 0.12\u20130.30) and 0.01 cases (95% CI: 0.005\u20130.02) per 100,000 live births, respectively.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec id=\"j_jpem-2020-0742_abs_005\">\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Based on the global population size (7.8 billion) and the life span of patients, there would be 12\u201319 thousand mucopolysaccharidosis III patients worldwide. To our knowledge, this is the first comprehensive systematic review that presented quantitative data fundamental for evidence-based public health decision-making by evaluating global epidemiology of mucopolysaccharidosis III.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1515\/jpem-2020-0742","type":"journal-article","created":{"date-parts":[[2021,7,16]],"date-time":"2021-07-16T22:04:51Z","timestamp":1626473091000},"page":"1225-1235","source":"Crossref","is-referenced-by-count":25,"title":["Global epidemiology of mucopolysaccharidosis type III (Sanfilippo syndrome): an updated systematic review and meta-analysis"],"prefix":"10.1515","volume":"34","author":[{"given":"Weijing","family":"Kong","sequence":"first","affiliation":[{"name":"Department of Pediatrics , Beijing Friendship Hospital, Capital Medical University , Beijing , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shanshan","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Clinical Epidemiology and EBM , Beijing Friendship Hospital, Capital Medical University , Beijing , China"},{"name":"Clinical Research Center for Digestive Diseases , Beijing Friendship Hospital, Capital Medical University , Beijing , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Pediatrics , Beijing Friendship Hospital, Capital Medical University , Beijing , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng","family":"Lu","sequence":"additional","affiliation":[{"name":"Beijing Hong Jian Medical Device Company , Beijing , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingxue","family":"Ding","sequence":"additional","affiliation":[{"name":"Department of Pediatrics , Beijing Friendship Hospital, Capital Medical University , Beijing , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2274-3249","authenticated-orcid":false,"given":"Yan","family":"Meng","sequence":"additional","affiliation":[{"name":"Department of Pediatrics , Chinese PLA General Hospital , Beijing , China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"374","published-online":{"date-parts":[[2021,7,19]]},"reference":[{"key":"2023040101125219394_j_jpem-2020-0742_ref_001","doi-asserted-by":"crossref","unstructured":"Kong, W, Meng, Y, Zou, L, Yang, G, Wang, J, Shi, X. Mucopolysaccharidosis III in Mainland China: natural history, clinical and molecular characteristics of 34 patients. J Pediatr Endocrinol Metab 2020;33:793\u2013802. https:\/\/doi.org\/10.1515\/jpem-2019-0505.","DOI":"10.1515\/jpem-2019-0505"},{"key":"2023040101125219394_j_jpem-2020-0742_ref_002","doi-asserted-by":"crossref","unstructured":"Valstar, MJ, Ruijter, GJ, van Diggelen, OP, Poorthuis, BJ, Wijburg, FA. Sanfilippo syndrome: a mini-review. J Inherit Metab Dis 2008;31:240\u201352. https:\/\/doi.org\/10.1007\/s10545-008-0838-5.","DOI":"10.1007\/s10545-008-0838-5"},{"key":"2023040101125219394_j_jpem-2020-0742_ref_003","doi-asserted-by":"crossref","unstructured":"Heon-Roberts, R, Nguyen, ALA, Pshezhetsky, AV. Molecular bases of neurodegeneration and cognitive decline, the major burden of Sanfilippo disease. J Clin Med 2020;9:344. https:\/\/doi.org\/10.3390\/jcm9020344.","DOI":"10.3390\/jcm9020344"},{"key":"2023040101125219394_j_jpem-2020-0742_ref_004","doi-asserted-by":"crossref","unstructured":"Fedele, AO. Sanfilippo syndrome: causes, consequences, and treatments. Appl Clin Genet 2015;8:269\u201381. https:\/\/doi.org\/10.2147\/TACG.S57672.","DOI":"10.2147\/TACG.S57672"},{"key":"2023040101125219394_j_jpem-2020-0742_ref_005","doi-asserted-by":"crossref","unstructured":"Bilginer Gurbuz, B, Aypar, E, Coskun, T, Alehan, D, Dursun, A, Tokatli, A, et al.. The effectiveness of enzyme replacement therapy on cardiac findings in patients with mucopolysaccharidosis. J Pediatr Endocrinol Metab 2019;32:1049\u201353. https:\/\/doi.org\/10.1515\/jpem-2019-0293.","DOI":"10.1515\/jpem-2019-0293"},{"key":"2023040101125219394_j_jpem-2020-0742_ref_006","doi-asserted-by":"crossref","unstructured":"Kong, W, Yao, Y, Zhang, J, Lu, C, Ding, Y, Meng, Y. Update of treatment for mucopolysaccharidosis type III (Sanfilippo syndrome). Eur J Pharmacol 2020;888:173562. https:\/\/doi.org\/10.1016\/j.ejphar.2020.173562.","DOI":"10.1016\/j.ejphar.2020.173562"},{"key":"2023040101125219394_j_jpem-2020-0742_ref_007","doi-asserted-by":"crossref","unstructured":"Tambuyzer, E, Vandendriessche, B, Austin, CP, Brooks, PJ, Larsson, K, Needleman, KIM, et al.. Therapies for rare diseases: therapeutic modalities, progress and challenges ahead. Nat Rev Drug Discov 2020;19:93\u2013111. https:\/\/doi.org\/10.1038\/s41573-019-0049-9.","DOI":"10.1038\/s41573-019-0049-9"},{"key":"2023040101125219394_j_jpem-2020-0742_ref_008","doi-asserted-by":"crossref","unstructured":"Khan, SA, Peracha, H, Ballhausen, D, Wiesbauer, A, Rohrbach, M, Gautschi, M, et al.. Epidemiology of mucopolysaccharidoses. Mol Genet Metabol 2017;121:227\u201340. https:\/\/doi.org\/10.1016\/j.ymgme.2017.05.016.","DOI":"10.1016\/j.ymgme.2017.05.016"},{"key":"2023040101125219394_j_jpem-2020-0742_ref_009","doi-asserted-by":"crossref","unstructured":"Zelei, T, Csetneki, K, Voko, Z, Siffel, C. Epidemiology of Sanfilippo syndrome: results of a systematic literature review. Orphanet J Rare Dis 2018;13:53. https:\/\/doi.org\/10.1186\/s13023-018-0796-4.","DOI":"10.1186\/s13023-018-0796-4"},{"key":"2023040101125219394_j_jpem-2020-0742_ref_010","doi-asserted-by":"crossref","unstructured":"Celik, B, Tomatsu, SC, Tomatsu, S, Khan, SA. Epidemiology of mucopolysaccharidoses update. Diagnostics 2021;11:273. https:\/\/doi.org\/10.3390\/diagnostics11020273.","DOI":"10.3390\/diagnostics11020273"},{"key":"2023040101125219394_j_jpem-2020-0742_ref_011","doi-asserted-by":"crossref","unstructured":"Moher, D, Liberati, A, Tetzlaff, J, Altman, DG, Group, P. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. J Clin Epidemiol 2009;62:1006\u201312. https:\/\/doi.org\/10.1016\/j.jclinepi.2009.06.005.","DOI":"10.1016\/j.jclinepi.2009.06.005"},{"key":"2023040101125219394_j_jpem-2020-0742_ref_012","doi-asserted-by":"crossref","unstructured":"Leadley, RM, Lang, S, Misso, K, Bekkering, T, Ross, J, Akiyama, T, et al.. A systematic review of the prevalence of Morquio A syndrome: challenges for study reporting in rare diseases. Orphanet J Rare Dis 2014;9:173. https:\/\/doi.org\/10.1186\/s13023-014-0173-x.","DOI":"10.1186\/s13023-014-0173-x"},{"key":"2023040101125219394_j_jpem-2020-0742_ref_013","doi-asserted-by":"crossref","unstructured":"Crisafulli, S, Sultana, J, Fontana, A, Salvo, F, Messina, S, Trifiro, G. Global epidemiology of Duchenne muscular dystrophy: an updated systematic review and meta-analysis. Orphanet J Rare Dis 2020;15:141. https:\/\/doi.org\/10.1186\/s13023-020-01430-8.","DOI":"10.1186\/s13023-020-01430-8"},{"key":"2023040101125219394_j_jpem-2020-0742_ref_014","doi-asserted-by":"crossref","unstructured":"Higgins, JP, Thompson, SG, Deeks, JJ, Altman, DG. Measuring inconsistency in meta-analyses. Br Med J 2003;327:557\u201360. https:\/\/doi.org\/10.1136\/bmj.327.7414.557.","DOI":"10.1136\/bmj.327.7414.557"},{"key":"2023040101125219394_j_jpem-2020-0742_ref_015","doi-asserted-by":"crossref","unstructured":"Gammie, T, Lu, CY, Babar, ZU. Access to orphan drugs: a comprehensive review of legislations, regulations and policies in 35 countries. PloS One 2015;10:e0140002. https:\/\/doi.org\/10.1371\/journal.pone.0140002.","DOI":"10.1371\/journal.pone.0140002"},{"key":"2023040101125219394_j_jpem-2020-0742_ref_016","doi-asserted-by":"crossref","unstructured":"Wakap, SN, Lambert, DM, Olry, A, Rodwell, C, Gueydan, C, Lanneau, V, et al.. Estimating cumulative point prevalence of rare diseases: analysis of the Orphanet database. Eur J Hum Genet 2020;28:165\u201373. https:\/\/doi.org\/10.1038\/s41431-019-0508-0.","DOI":"10.1038\/s41431-019-0508-0"},{"key":"2023040101125219394_j_jpem-2020-0742_ref_017","unstructured":"WHO. Global Health Estimates: Life expectancy and leading causes of death and disability [Internet]. World Health Organization; 2019. Available from: https:\/\/www.who.int\/data\/gho\/data\/themes\/mortality-and-global-health-estimates."},{"key":"2023040101125219394_j_jpem-2020-0742_ref_018","doi-asserted-by":"crossref","unstructured":"Lavery, C, Hendriksz, CJ, Jones, SA. Mortality in patients with Sanfilippo syndrome. Orphanet J Rare Dis 2017;12:168. https:\/\/doi.org\/10.1186\/s13023-017-0717-y.","DOI":"10.1186\/s13023-017-0717-y"},{"key":"2023040101125219394_j_jpem-2020-0742_ref_019","doi-asserted-by":"crossref","unstructured":"Poorthuis, BJ, Wevers, RA, Kleijer, WJ, Groener, JE, de Jong, JG, van Weely, S, et al.. The frequency of lysosomal storage diseases in The Netherlands. Hum Genet 1999;105:151\u20136. https:\/\/doi.org\/10.1007\/s004399900075.","DOI":"10.1007\/s004399900075"},{"key":"2023040101125219394_j_jpem-2020-0742_ref_020","doi-asserted-by":"crossref","unstructured":"Valstar, MJ, Bertoli-Avella, AM, Wessels, MW, Ruijter, GJ, de Graaf, B, Olmer, R, et al.. Mucopolysaccharidosis type IIID: 12 new patients and 15 novel mutations. Hum Mutat 2010;31:E1348\u201360. https:\/\/doi.org\/10.1002\/humu.21234.","DOI":"10.1002\/humu.21234"},{"key":"2023040101125219394_j_jpem-2020-0742_ref_021","doi-asserted-by":"crossref","unstructured":"Joshi, SN, Hashim, J, Venugopalan, P. Pattern of inborn errors of metabolism in an Omani population of the Arabian Peninsula. Ann Trop Paediatr 2002;22:93\u20136. https:\/\/doi.org\/10.1179\/027249302125000238.","DOI":"10.1179\/027249302125000238"},{"key":"2023040101125219394_j_jpem-2020-0742_ref_022","doi-asserted-by":"crossref","unstructured":"Al-Maawali, AA, Joshi, SN, Koul, RL, Al-Maawali, AA, Al-Sedari, HS, Al-Amri, BM, et al.. Spectrum of paediatric lysosomal storage disorders in Oman. Sultan Qaboos Univ Med J 2012;12:295\u20139. https:\/\/doi.org\/10.12816\/0003142.","DOI":"10.12816\/0003142"},{"key":"2023040101125219394_j_jpem-2020-0742_ref_023","doi-asserted-by":"crossref","unstructured":"Moammar, H, Cheriyan, G, Mathew, R, Al-Sannaa, N. Incidence and patterns of inborn errors of metabolism in the Eastern Province of Saudi Arabia, 1983\u20132008. Ann Saudi Med 2010;30:271\u20137. https:\/\/doi.org\/10.4103\/0256-4947.65254.","DOI":"10.4103\/0256-4947.65254"},{"key":"2023040101125219394_j_jpem-2020-0742_ref_024","doi-asserted-by":"crossref","unstructured":"Cho, SY, Sohn, YB, Jin, DK. An overview of Korean patients with mucopolysaccharidosis and collaboration through the Asia Pacific MPS Network. Intractable Rare Dis Res 2014;3:79\u201386. https:\/\/doi.org\/10.5582\/irdr.2014.01013.","DOI":"10.5582\/irdr.2014.01013"},{"key":"2023040101125219394_j_jpem-2020-0742_ref_025","doi-asserted-by":"crossref","unstructured":"Lin, HY, Lin, SP, Chuang, CK, Niu, DM, Chen, MR, Tsai, FJ, et al.. Incidence of the mucopolysaccharidoses in taiwan, 1984\u20132004. Am J Med Genet 2009;149A:960\u20134. https:\/\/doi.org\/10.1002\/ajmg.a.32781.","DOI":"10.1002\/ajmg.a.32781"},{"key":"2023040101125219394_j_jpem-2020-0742_ref_026","doi-asserted-by":"crossref","unstructured":"Federhen, A, Pasqualim, G, de Freitas, TF, Gonzalez, EA, Trapp, F, Matte, U, et al.. Estimated birth prevalence of mucopolysaccharidoses in Brazil. Am J Med Genet 2020;182:469\u201383. https:\/\/doi.org\/10.1002\/ajmg.a.61456.","DOI":"10.1002\/ajmg.a.61456"},{"key":"2023040101125219394_j_jpem-2020-0742_ref_027","doi-asserted-by":"crossref","unstructured":"Josahkian, JA, Trapp, FB, Burin, MG, Michelin-Tirelli, K, Magalhaes, A, Sebastiao, FM, et al.. Updated birth prevalence and relative frequency of mucopolysaccharidoses across Brazilian regions. Genet Mol Biol 2021;44: e20200138. https:\/\/doi.org\/10.1590\/1678-4685-GMB-2020-0138.","DOI":"10.1590\/1678-4685-gmb-2020-0138"},{"key":"2023040101125219394_j_jpem-2020-0742_ref_028","doi-asserted-by":"crossref","unstructured":"Valdez, R, Ouyang, L, Bolen, J. Public health and rare diseases: oxymoron no more. Prev Chronic Dis 2016;13:E05. https:\/\/doi.org\/10.5888\/pcd13.150491.","DOI":"10.5888\/pcd13.150491"},{"key":"2023040101125219394_j_jpem-2020-0742_ref_029","doi-asserted-by":"crossref","unstructured":"Fabie, NAV, Pappas, KB, Feldman, GL. The current state of newborn screening in the United States. Pediatr Clin 2019;66:369\u201386. https:\/\/doi.org\/10.1016\/j.pcl.2018.12.007.","DOI":"10.1016\/j.pcl.2018.12.007"},{"key":"2023040101125219394_j_jpem-2020-0742_ref_030","doi-asserted-by":"crossref","unstructured":"Lew, RM, Burnett, L, Proos, AL, Barlow-Stewart, K, Delatycki, MB, Bankier, A, et al.. Ashkenazi Jewish population screening for Tay-Sachs disease: the international and Australian experience. J Paediatr Child Health 2015;51:271\u20139. https:\/\/doi.org\/10.1111\/jpc.12632.","DOI":"10.1111\/jpc.12632"},{"key":"2023040101125219394_j_jpem-2020-0742_ref_031","doi-asserted-by":"crossref","unstructured":"Brownson, RC, Fielding, JE, Maylahn, CM. Evidence-based public health: a fundamental concept for public health practice. Annu Rev Publ Health 2009;30:175\u2013201. https:\/\/doi.org\/10.1146\/annurev.publhealth.031308.100134.","DOI":"10.1146\/annurev.publhealth.031308.100134"},{"key":"2023040101125219394_j_jpem-2020-0742_ref_032","doi-asserted-by":"crossref","unstructured":"Schaap, T, Bach, G. Incidence of mucopolysaccharidoses in Israel: is Hunter disease a \u201cJewish disease\u201d? Hum Genet 1980;56:221\u20133. https:\/\/doi.org\/10.1007\/BF00295699.","DOI":"10.1007\/BF00295699"},{"key":"2023040101125219394_j_jpem-2020-0742_ref_033","doi-asserted-by":"crossref","unstructured":"Lowry, RB, Applegarth, DA, Toone, JR, MacDonald, E, Thunem, NY. An update on the frequency of mucopolysaccharide syndromes in British Columbia. Hum Genet 1990;85:389\u201390. https:\/\/doi.org\/10.1007\/BF00206770.","DOI":"10.1007\/BF00206770"},{"key":"2023040101125219394_j_jpem-2020-0742_ref_034","doi-asserted-by":"crossref","unstructured":"Nelson, J. Incidence of the mucopolysaccharidoses in northern Ireland. Hum Genet 1997;101:355\u20138. https:\/\/doi.org\/10.1007\/s004390050641.","DOI":"10.1007\/s004390050641"},{"key":"2023040101125219394_j_jpem-2020-0742_ref_035","doi-asserted-by":"crossref","unstructured":"Hutchesson, AC, Bundey, S, Preece, MA, Hall, SK, Green, A. A comparison of disease and gene frequencies of inborn errors of metabolism among different ethnic groups in the West Midlands, UK. J Med Genet 1998;35:366\u201370. https:\/\/doi.org\/10.1136\/jmg.35.5.366.","DOI":"10.1136\/jmg.35.5.366"},{"key":"2023040101125219394_j_jpem-2020-0742_ref_036","doi-asserted-by":"crossref","unstructured":"Applegarth, DA, Toone, JR, Lowry, RB. Incidence of inborn errors of metabolism in British Columbia, 1969\u20131996. Pediatrics 2000;105:e10. https:\/\/doi.org\/10.1542\/peds.105.1.e10.","DOI":"10.1542\/peds.105.1.e10"},{"key":"2023040101125219394_j_jpem-2020-0742_ref_037","doi-asserted-by":"crossref","unstructured":"Dionisi-Vici, C, Rizzo, C, Burlina, AB, Caruso, U, Sabetta, G, Uziel, G, et al.. Inborn errors of metabolism in the Italian pediatric population: a national retrospective survey. J Pediatr 2002;140:321\u20137. https:\/\/doi.org\/10.1067\/mpd.2002.122394.","DOI":"10.1067\/mpd.2002.122394"},{"key":"2023040101125219394_j_jpem-2020-0742_ref_038","doi-asserted-by":"crossref","unstructured":"Nelson, J, Crowhurst, J, Carey, B, Greed, L. Incidence of the mucopolysaccharidoses in Western Australia. Am J Med Genet 2003;123A:310\u20133. https:\/\/doi.org\/10.1002\/ajmg.a.20314.","DOI":"10.1002\/ajmg.a.20314"},{"key":"2023040101125219394_j_jpem-2020-0742_ref_039","doi-asserted-by":"crossref","unstructured":"Baehner, F, Schmiedeskamp, C, Krummenauer, F, Miebach, E, Bajbouj, M, Whybra, C, et al.. Cumulative incidence rates of the mucopolysaccharidoses in Germany. J Inherit Metab Dis 2005;28:1011\u20137. https:\/\/doi.org\/10.1007\/s10545-005-0112-z.","DOI":"10.1007\/s10545-005-0112-z"},{"key":"2023040101125219394_j_jpem-2020-0742_ref_040","doi-asserted-by":"crossref","unstructured":"Malm, G, Lund, AM, Mansson, JE, Heiberg, A. Mucopolysaccharidoses in the Scandinavian countries: incidence and prevalence. Acta Paediatr 2008;97:1577\u201381. https:\/\/doi.org\/10.1111\/j.1651-2227.2008.00965.x.","DOI":"10.1111\/j.1651-2227.2008.00965.x"},{"key":"2023040101125219394_j_jpem-2020-0742_ref_041","unstructured":"Ben Turkia, H, Tebib, N, Azzouz, H, Abdelmoula, MS, Ben Chehida, A, Chemli, J, et al.. Incidence of mucopolysaccharidoses in Tunisia. Tunis Med 2009;87:782\u20135."},{"key":"2023040101125219394_j_jpem-2020-0742_ref_042","doi-asserted-by":"crossref","unstructured":"Poupetova, H, Ledvinova, J, Berna, L, Dvorakova, L, Kozich, V, Elleder, M. The birth prevalence of lysosomal storage disorders in the Czech Republic: comparison with data in different populations. J Inherit Metab Dis 2010;33:387\u201396. https:\/\/doi.org\/10.1007\/s10545-010-9093-7.","DOI":"10.1007\/s10545-010-9093-7"},{"key":"2023040101125219394_j_jpem-2020-0742_ref_043","doi-asserted-by":"crossref","unstructured":"Heron, B, Mikaeloff, Y, Froissart, R, Caridade, G, Maire, I, Caillaud, C, et al.. Incidence and natural history of mucopolysaccharidosis type III in France and comparison with United Kingdom and Greece. Am J Med Genet 2011;155A:58\u201368. https:\/\/doi.org\/10.1002\/ajmg.a.33779.","DOI":"10.1002\/ajmg.a.33779"},{"key":"2023040101125219394_j_jpem-2020-0742_ref_044","doi-asserted-by":"crossref","unstructured":"G\u00f3mez, AM, Garc\u00eda-Robles, R, Su\u00e1rez-Obando, F. Estimation of the mucopolysaccharidoses frequencies and cluster analysis in the colombian provinces of cundinamarca and boyac\u00e1. Biomedica 2012;32:602\u20139. https:\/\/doi.org\/10.7705\/biomedica.v32i4.574.","DOI":"10.7705\/biomedica.v32i4.574"},{"key":"2023040101125219394_j_jpem-2020-0742_ref_045","doi-asserted-by":"crossref","unstructured":"Krabbi, K, Joost, K, Zordania, R, Talvik, I, Rein, R, Huijmans, JG, et al.. The live-birth prevalence of mucopolysaccharidoses in Estonia. Genet Test Mol Biomarkers 2012;16:846\u20139. https:\/\/doi.org\/10.1089\/gtmb.2011.0307.","DOI":"10.1089\/gtmb.2011.0307"},{"key":"2023040101125219394_j_jpem-2020-0742_ref_046","doi-asserted-by":"crossref","unstructured":"Hult, M, Darin, N, von Dobeln, U, Mansson, JE. Epidemiology of lysosomal storage diseases in Sweden. Acta Paediatr 2014;103:1258\u201363. https:\/\/doi.org\/10.1111\/apa.12807.","DOI":"10.1111\/apa.12807"},{"key":"2023040101125219394_j_jpem-2020-0742_ref_047","doi-asserted-by":"crossref","unstructured":"Jurecka, A, Lugowska, A, Golda, A, Czartoryska, B, Tylki-Szymanska, A. Prevalence rates of mucopolysaccharidoses in Poland. J Appl Genet 2015;56:205\u201310. https:\/\/doi.org\/10.1007\/s13353-014-0262-5.","DOI":"10.1007\/s13353-014-0262-5"},{"key":"2023040101125219394_j_jpem-2020-0742_ref_048","doi-asserted-by":"crossref","unstructured":"Alfadhel, M, Benmeakel, M, Hossain, MA, Al Mutairi, F, Al Othaim, A, Alfares, AA, et al.. Thirteen year retrospective review of the spectrum of inborn errors of metabolism presenting in a tertiary center in Saudi Arabia. Orphanet J Rare Dis 2016;11:126. https:\/\/doi.org\/10.1186\/s13023-016-0510-3.","DOI":"10.1186\/s13023-016-0510-3"},{"key":"2023040101125219394_j_jpem-2020-0742_ref_049","doi-asserted-by":"crossref","unstructured":"Chien, YH, Lee, NC, Chen, PW, Yeh, HY, Gelb, MH, Chiu, PC, et al.. Newborn screening for Morquio disease and other lysosomal storage diseases: results from the 8-plex assay for 70,000 newborns. Orphanet J Rare Dis 2020;15:38. https:\/\/doi.org\/10.1186\/s13023-020-1322-z.","DOI":"10.1186\/s13023-020-1322-z"}],"container-title":["Journal of Pediatric Endocrinology and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.degruyter.com\/document\/doi\/10.1515\/jpem-2020-0742\/xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.degruyter.com\/document\/doi\/10.1515\/jpem-2020-0742\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T18:57:20Z","timestamp":1680375440000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.degruyter.com\/document\/doi\/10.1515\/jpem-2020-0742\/html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,19]]},"references-count":49,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2021,7,20]]},"published-print":{"date-parts":[[2021,10,26]]}},"alternative-id":["10.1515\/jpem-2020-0742"],"URL":"https:\/\/doi.org\/10.1515\/jpem-2020-0742","relation":{},"ISSN":["0334-018X","2191-0251"],"issn-type":[{"value":"0334-018X","type":"print"},{"value":"2191-0251","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,19]]}}}